QUINIDINE AND DIHYDROQUINIDINE INTERACTIONS IN HUMAN-PLASMA

被引:13
作者
UEDA, CT
MAKOID, MC
机构
[1] UNIV NEBRASKA,MED CTR,COLL PHARM,CLIN PHARMACOKINET LAB,OMAHA,NE 68105
[2] UNIV NEBRASKA,MED CTR,CTR CARDIOVASC,OMAHA,NE 68105
关键词
Dihydroquinidine—protein binding; effects on quinidine interactions with plasma constituents; Interactions—quinidine and dihydroquinidine in human plasma; Protein binding—quinidine and dihydroquinidine; interactions in plasma; Quinidine—interactions with plasma constituents; effects of dihydroquinidine on binding;
D O I
10.1002/jps.2600680414
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The protein‐binding characteristics of dihydroquinidine, a known impurity in drug grade quinidine, in human plasma and the effects of dihydroquinidine on quinidine interactions with these plasma constituents were studied by equilibrium dialysis. In the plasma concentration range of 1.75–23.0 mg/liter, dihydroquinidine binding was similar to the binding observed with quinidine. The data suggested the presence of a single class of binding sites for both compounds in the plasma drug concentration range and samples studied. The mean values for the association constant, K, and the total concentration of binding sites, nPt, for dihydroquinidine were 4.75 ± 0.67 × 104 M−1 and 5.78 ± 0.17 × 10−5 M., respectively. The corresponding values for quinidine were 4.78 ± 1.00 × 104 M−1 and 5.65 ± 0.48 × 10−5 M. In the presence of 5 and 10% (of total alkaloid content) dihydroquinidine, the plasma concentration of unbound quinidine did not change significantly. At a 20% level of dihydroquinidine, however, an increase in unbound quinidine was observed (p < 0.05). The elevations in free quinidine concentrations were directly related to the level of dihydroquinidine present. The results of this study indicate that the interactions between dihydroquinidine and quinidine for binding sites on human plasma proteins are competitive. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:448 / 450
页数:3
相关论文
共 21 条
[1]   COMPARATIVE BINDING OF DISOPYRAMIDE PHOSPHATE AND QUINIDINE SULFATE TO HUMAN PLASMA-PROTEINS [J].
CHIEN, YW ;
LAMBERT, HJ ;
KARIM, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (12) :1877-1879
[2]   SOME QUANTITATIVE ASPECTS OF BINDING OF QUINIDINE AND RELATED QUINOLINE COMPOUNDS BY HUMAN SERUM ALBUMIN [J].
CONN, HL ;
LUCHI, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1961, 40 (03) :509-&
[3]   QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA [J].
CRAMER, G ;
ISAKSSON, B .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1963, 15 (05) :553-&
[4]   INFLUENCE OF BINDING ON DRUG-METABOLISM AND DISTRIBUTION [J].
DAYTON, PG ;
ISRAILI, ZH ;
PEREL, JM .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1973, 226 (NOV26) :172-194
[5]   Syntheses in the cinchona series I The simpler cinchona alkaloids and their dihydro derivatives [J].
Heidelberger, M ;
Jacobs, WA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1919, 41 :817-833
[6]  
KLOTZ IM, 1946, ARCH BIOCHEM, V9, P109
[7]  
KOCHWESER J, 1972, BASIS DRUG THERAPY M, P56
[8]   INTERPRETATION OF PROTEIN-DRUG INTERACTION THROUGH FRACTION BOUND AND RELATIVE CONTRIBUTION OF SECONDARY SITES [J].
MAIS, RF ;
KERESZTE.S ;
ZAROSLIN.JF ;
OESTER, YT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (09) :1423-1427
[9]   BINDING OF DRUGS BY PLASMA PROTEINS [J].
MEYER, MC ;
GUTTMAN, DE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (06) :895-+
[10]   USE OF 2-(4'-HYDROXYBENZENEAZO)BENZOIC ACID TO STUDY BINDING OF L-THYROXINE TO SERUM ALBUMINS [J].
NAZARETH, RI ;
SOKOLOSKI, TD ;
WITIAK, DT ;
HOPPER, AT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (02) :199-202